GLONGHUI, May 22 | According to Novi Zanofficial WeChat, GLP-1 drugs have become the focus of research and development of new drugs for obesity due to their excellent clinical data and efficacy. Testing the activity of GLP-1RA drugs is a key part of the drug development process. Currently, the mainstream method is luciferase reporter gene method. Novizan can provide detection reagents and corresponding solutions to accelerate the progress of GLP-1RA drug development. Currently, it has supplied several GLP-1RA drug development projects that have entered the clinical stage.
诺唯赞：荧光素酶报告基因检测试剂助力“减肥神药”GLP-1RA药物研发
Norvizan: Luciferase reporting genetic testing reagent helps develop the “magic drug for weight loss” GLP-1RA
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.